Certified by Founder Lodge
Acorn Bioventures
United States - New York, NY
INVESTOR
1 Disclosed Funding Rounds $108,000,000
2 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We invest in and partner with private and small capitalization biotech, specialty pharma and medical device companies.
| Company | Date | Round | Raised |
|---|---|---|---|
 Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
 Neuron23 |
June, 26 ,2025 | Series D | $96,500,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
Humble Robotics | $24,000,000 | (Apr 22, 2026)
Sinai.ai | $1,450,000 | (Apr 22, 2026)
NeoCognition | $40,000,000 | (Apr 22, 2026)
Qualitate | $7,000,000 | (Apr 22, 2026)
Deep Blue Medical Advances, Inc. | $5,600,000 | (Apr 22, 2026)
